Johnson & Johnson has added to the flurry of M&A deals in pharma with an agreement to buy US biotech Halda Therapeutics and ...
BMS and J&J's Librexia AF study is also comparing milvexian to Eliquis to see if it can prevent stroke and other clotting ...
The announcement takes the total raised by Sofinnova Partners in the last year to €1.5 billion, and comes shortly after Anglo ...
A 2024 survey by the American Medical Association showed that physician usage of AI jumped 78% in a single year, which tells ...
AbbVie has turned to award-winning, Oscar-nominated director Dominic Gill to help it highlight the lives of people living ...
Shares in Sarepta reversed some of their recent declines after the FDA added a warning label to its Duchenne muscular ...
In a statement, Avadel acknowledged that it had received the Lundbeck bid and that its board of directors had "determined in ...
MSD has announced a takeover deal for Cidara Therapeutics, an infectious disease specialist currently focused on developing a ...
On World Diabetes Day, Sanofi is celebrating an approval recommendation in the EU for Teizeild, a first-in-class drug ...
Alkermes already has positive results for alixorexton in NT1 from the phase 2 Vibrance-1, while Takeda is developing another ...
The $6.7 billion merger brought together two companies that had been forced to file for bankruptcy protection due to opioid ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback